000710 贝瑞基因
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.496-20.512-10.403-4.7898.932
总资产报酬率 ROA (%)0.328-14.372-7.411-3.4536.674
投入资产回报率 ROIC (%)0.384-16.689-8.587-3.9947.738

边际利润分析
销售毛利率 (%)52.19544.74542.71644.73552.625
营业利润率 (%)3.931-39.147-20.469-8.24415.916
息税前利润/营业总收入 (%)4.604-38.117-18.921-7.81416.877
净利润/营业总收入 (%)2.187-36.934-18.012-8.13613.353

收益指标分析
经营活动净收益/利润总额(%)206.81711.46618.0699.74092.812
价值变动净收益/利润总额(%)-24.55513.63252.21438.60416.873
营业外收支净额/利润总额(%)-4.1820.591-1.3177.8680.075

偿债能力分析
流动比率 (X)1.5851.9302.4502.4723.609
速动比率 (X)1.3721.6302.1232.1673.285
资产负债率 (%)34.28130.88327.28828.3450.253
带息债务/全部投入资本 (%)23.44017.89716.24815.75914.988
股东权益/带息债务 (%)319.836448.824506.053525.719560.463
股东权益/负债合计 (%)188.321220.188263.266249.427290.734
利息保障倍数 (X)5.542-30.192-14.764-6.89117.774

营运能力分析
应收账款周转天数 (天)275.768291.137283.014274.196223.209
存货周转天数 (天)147.854130.215106.76994.847148.519